Stay updated on CM-AT Clinical Trial Extension in Children With Autism
Sign up to get notified when there's something new on the CM-AT Clinical Trial Extension in Children With Autism page.

Latest updates to the CM-AT Clinical Trial Extension in Children With Autism page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedThe record describes a completed Phase 3 open-label extension study of CM-AT for children with autism, including its eligibility criteria, participating locations, and behavioral outcome measures. The study is no longer recruiting participants.SummaryDifference44%

- Check17 days agoChange DetectedThe ClinicalTrials.gov footer revision changed from v3.7.2 to v3.8.0, while the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check24 days agoChange DetectedA site-wide notice announces that NIH is transitioning from the term “Artificial Intelligence” to “Super Intelligence” under Executive Order 14434.SummaryDifference1%

- Check31 days agoChange DetectedThe footer’s site revision label changed from v3.7.1 to v3.7.2 on the 403 error page.SummaryDifference0.2%

- Check38 days agoChange DetectedThe revision identifier in the footer changes from v3.7.0 to v3.7.1, while the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check52 days agoChange DetectedThe 403 Forbidden page is replaced with the actual study details content for NCT00912691, making the study information visible again. The page now presents the study details content instead of the error notice.SummaryDifference0.5%

Stay in the know with updates to CM-AT Clinical Trial Extension in Children With Autism
Enter your email address, and we'll notify you when there's something new on the CM-AT Clinical Trial Extension in Children With Autism page.